@hadeanventures

Ribbon Biolabs appoints Jodi Barrientos Chief Executive Officer; Founder Harold De Vladar named an advisor…

Continue Reading

Complement Therapeutics Enrols First US Participant in the Non-interventional i-GAIN Study of People Diagnosed with…

Continue Reading

Abliva AB (Nasdaq Stockholm: ABLI) a clinical-stage company developing drugs for the treatment of rare…

Continue Reading

Abliva’s Lead Candidate KL1333 Receives FDA Fast Track Designation Abliva AB (Nasdaq Stockholm: ABLI) a…

Continue Reading

Arthex Biotech is a Spanish biopharmaceutical company developing advanced RNA treatments...

Continue Reading

ARTHEx Biotech Announces Closing of €42 M Series B Financing to Advance ATX-01, its Novel…

Continue Reading

Complement Therapeutics GmbH is a German headquartered biotechnology company...

Continue Reading

Complement Therapeutics Secures €72 Million in Series A Financing...

Continue Reading

Innovestor Life Science, a leading biotech and digital health VC, invests €1.25M in the digital…

Continue Reading

Stockholm, 5th December 2022 — Alex Therapeutics and Vicore Pharma today announce the first study…

Continue Reading